Histologic features predicting postoperative Crohn's disease recurrence

Inflammatory Bowel Diseases

Volumn 21, Issue 2, 2015, Pages 468-475

  Bressenot, Aude ^a   Peyrin Biroulet, Laurent ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Crohn's disease; Histologic features; Postoperative recurrence

Indexed keywords

BLOOD VESSEL PARAMETERS; CELL STRUCTURE; CROHN DISEASE; EXPERIMENTAL MODEL; HISTOPATHOLOGY; HUMAN; LYMPH VESSEL; MYENTERIC PLEXUS; NONHUMAN; PANETH CELL; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS;

CROHN DISEASE; HUMANS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE;

EID: 84927711182     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000224     Document Type: Review

References (60)

1. Buisson A, Chevaux J-B, Allen PB, et al. Review article: The natural history of postoperative Crohn's disease recurrence. Aliment Pharmacol Ther. 2012;35:625-633.
2. Peyrin-Biroulet L, Loftus EV Jr, Colombel J-F, et al. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol. 2010;105:289-297.
3. Crohn B, Ginzburg I, Oppenheimer G. D.Regional ileitis: A pathological and clinical entity. Crohn, B.B., Ginzburg, I. & Oppenheimer, G.D. JAMA. 1932:1323-1329.
4. Strong SA. Prognostic parameters of Crohn's disease recurrence. Baillières Clin Gastroenterol. 1998;12:167-177.
5. Williams JG, Wong WD, Rothenberger DA, et al. Recurrence of Crohn's disease after resection. Br J Surg. 1991;78:10-19.
6. Ahmed T, Rieder F, Fiocchi C, et al. Pathogenesis of postoperative recurrence in Crohn's disease. Gut. 2011;60:553-562.
7. Rigby RJ, Hunt MR, Scull BP, et al. A new animal model of postsurgical bowel inflammation and fibrosis: The effect of commensal microflora. Gut. 2009;58:1104-1112.
8. Borowiec AM, Sydora BC, Doyle J, et al. Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice. J Surg Res. 2012;178:147-154.
9. Rutgeerts P, Geboes K, Vantrappen G, et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 1984;25:665-672.
10. D'Haens GR, Geboes K, Peeters M, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262-267.
11. Rutgeerts P, Goboes K, Peeters M, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991; 338:771-774.
12. Rosman AS, Melis M, Fichera A. Metaanalysis of trials comparing laparoscopic and open surgery for Crohn's disease. Surg Endosc. 2005;19:1549-1555.
13. Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum. 1996;39:335-341.
14. Scarpa M, Ruffolo C, Bertin E, et al. Surgical predictors of recurrence of Crohn's disease after ileocolonic resection. Int J Colorectal Dis. 2007;22: 1061-1069.
15. Ferrante M, de Hertogh G, Hlavaty T, et al. The value of myenteric plexitis to predict early postoperative Crohn's disease recurrence. Gastroenterology. 2006;130:1595-1606.
16. Geboes K, Rutgeerts P, Ectors N, et al. Major histocompatibility class II expression on the small intestinal nervous system in Crohn's disease. Gastroenterology. 1992;103:439-447.
17. Geboes K, Collins S. Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis. Neurogastroenterol Motil. 1998;10:189-202.
18. di Mola FF, Friess H, Zhu ZW, et al. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut. 2000;46:670-679.
19. Belai A, Boulos PB, Robson T, et al. Neurochemical coding in the small intestine of patients with Crohn's disease. Gut. 1997;40:767-774.
20. Steinkamp M, Geerling I, Seufferlein T, et al. Glial-derived neurotrophic factor regulates apoptosis in colonic epithelial cells. Gastroenterology. 2003;124:1748-1757.
21. Cornet A, Savidge TC, Cabarrocas J, et al. Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease? Proc Natl Acad Sci U S A. 2001;98:13306-13311.
22. VanDussen KL, Liu T-C, Li D, et al. Genetic variants synthesize to produce paneth cell phenotypes that define subtypes of Crohn's disease. Gastroenterology. 2014;146:200-209.
23. Chambers TJ, Morson BC. The granuloma in Crohn's disease. Gut. 1979; 20:269-274.
24. Mitchell DN, Rees RJ, Goswami KK. Transmissible agents from human sarcoid and Crohn's disease tissues. Lancet. 1976;2:761-765.
25. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol. 2005;11:3971-3979.
26. Heresbach D, Alexandre JL, Branger B, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease. Gut. 2005; 54:215-222.
27. Glass RE, Baker WN. Role of the granuloma in recurrent Crohn's disease. Gut. 1976;17:75-77.
28. Anseline PF, Wlodarczyk J, Murugasu R. Presence of granulomas is associated with recurrence after surgery for Crohn's disease: experience of a surgical unit. Br J Surg. 1997;84:78-82.
29. Simillis C, Jacovides M, Reese GE, et al. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum. 2010; 53:177-185.
30. Denoya P, Canedo J, Berho M, et al. Granulomas in Crohn's disease: does progression through the bowel layers affect presentation or predict recurrence? Colorectal Dis. 2011;13:1142-1147.
31. Kinchen J, Rajaratnam K, Kingston G, et al. The Presence of Microscopic Disease at the Resection Margins Predicts Post-Surgical Relapse in Crohn's Disease. Gastroenterology. 2012;142:S-189-S-190.
32. Lindhagen T, Ekelund G, Leandoer L, et al. Recurrence rate after surgical treatment of Crohn's disease. Scand J Gastroenterol. 1983;18: 1037-1044.
33. Shivananda S, Hordijk ML, Pena AS, et al. Crohn's disease: risk of recurrence and reoperation in a defined population. Gut. 1989;30:990-995.
34. Kåresen R, Serch-Hanssen A, Thoresen BO, et al. Crohn's disease: longterm results of surgical treatment. Scand J Gastroenterol. 1981;16:57-64.
35. Wolff BG, Beart RW Jr, Frydenberg HB, et al. The importance of disease free margins in resections for Crohn's disease. Dis Colon Rectum. 1983; 26:239-243.
36. Chardavoyne R, Flint GW, Pollack S, et al. Factors affecting recurrence following resection for Crohn's disease. Dis Colon Rectum. 1986;29:495-502.
37. Wettergren A, Christiansen J. Risk of recurrence and reoperation after resection for ileocolic Crohn's disease. Scand J Gastroenterol. 1991;26: 1319-1322.
38. Kotanagi H, Kramer K, Fazio VW, et al. Do microscopic abnormalities at resection margins correlate with increased anastomotic recurrence in Crohn's disease? Retrospective analysis of 100 cases. Dis Colon Rectum. 1991;34:909-916.
39. Fazio VW, Marchetti F, Church M, et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel. A randomized controlled trial. Ann Surg. 1996;224:563-571; discussion 571-573.
40. Pennington L, Hamilton SR, Bayless TM, et al. Surgical management of Crohn's disease. Influence of disease at margin of resection. Ann Surg. 1980;192:311-318.
41. Heuman R, Boeryd B, Bolin T, et al. The influence of disease at the margin of resection on the outcome of Crohn's disease. Br J Surg. 1983;70:519-521.
42. Hamilton SR, Reese J, Pennington L, et al. The role of resection margin frozen section in the surgical management of Crohn's disease. Surg Gynecol Obstet. 1985;160:57-62.
43. Cooper JC, Williams NS. The influence of microscopic disease at the margin of resection on recurrence rates in Crohn's disease. Ann R Coll Surg Engl. 1986;68:23-26.
44. Adloff M, Arnaud JP, Ollier JC. Does the histologic appearance at the margin of resection affect the postoperative recurrence rate in Crohn's disease? Am Surg. 1987;53:543-546.
45. Kurer MA, Stamou KM, Wilson TR, et al. Early symptomatic recurrence after intestinal resection in Crohn's disease is unpredictable. Colorectal Dis. 2007;9:567-571.
46. Heimann TM, Greenstein AJ, Lewis B, et al. Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease. Ann Surg. 1993;218:294-298; discussion 298-299.
47. Sokol H, Polin V, Lavergne-Slove A, et al. Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease. Gut. 2009; 58:1218-1225.
48. Ng SC, Lied GA, Kamm MA, et al. Predictive value and clinical significance of myenteric plexitis in Crohn's disease. Inflamm Bowel Dis. 2009;15:1499-1507.
49. Bressenot A, Chevaux J-B, Williet N, et al. Submucosal plexitis as a predictor of postoperative surgical recurrence in Crohn's disease. Inflamm Bowel Dis. 2013;19:1654-1661.
50. Rahier JF, De Beauce S, Dubuquoy L, et al. Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther. 2011;34:533-543.
51. Colombat M, Imbert A, Bruneval P, et al. Giant cell arteritis localized to the colon associated with Crohn's disease. Histopathology. 2001;38:21-24.
52. Hamilton MI, Dick R, Crawford L, et al. Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet. 1995;345:688-690.
53. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn's disease. Gut. 2008;57:1-4.
54. Sura R, Colombel JF, Van Kruiningen HJ. Lymphatics, tertiary lymphoid organs and the granulomas of Crohn's disease: An immunohistochemical study. Aliment Pharmacol Ther. 2011;33:930-939.
55. Stappenbeck TS. Paneth cell development, differentiation, and function: new molecular cues. Gastroenterology. 2009;137:30-33.
56. Salzman NH, Ghosh D, Huttner KM, et al. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature. 2003;422:522-526.
57. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol. 2010;11:76-83.
58. Ouellette AJ. Paneth cells and innate mucosal immunity. Curr Opin Gastroenterol. 2010;26:547-553.
59. Cadwell K, Liu JY, Brown SL, et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259-263.
60. Vuitton L, Koch S, Peyrin-Biroulet L. Preventing postoperative recurrence in Crohn's disease: what does the future hold? Drugs. 2013;73:1749-1759.